Billy Ray - Immunotech Laboratories Executive CFO
| IMMB Stock | USD 0.0001 0.00 0.00% |
CFO
Billy Ray is Executive CFO of Immunotech Laboratories
| Address | 120 West Pomona Avenue, Monrovia, CA, United States, 91016 |
| Phone | 626-538-4779 |
| Web | https://www.immunotechlab.com |
Immunotech Laboratories Leadership Team
Elected by the shareholders, the Immunotech Laboratories' board of directors comprises two types of representatives: Immunotech Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Immunotech. The board's role is to monitor Immunotech Laboratories' management team and ensure that shareholders' interests are well served. Immunotech Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Immunotech Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Esq JD, Legal Counsel | ||
| Harry Zhabilov, Vice Chairman of the Board, Chief Science Officer | ||
| Billy Ray, Executive CFO | ||
| Edward Azizian, VP Research | ||
| Zhabilov BSc, Vice Founder |
Immunotech Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Immunotech Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 1.25 M | ||||
| Shares Outstanding | 550.66 K | ||||
| Price To Book | 0.01 X | ||||
| EBITDA | (944.59 K) | ||||
| Net Income | (977.57 K) | ||||
| Book Value Per Share | 0.11 X | ||||
| Earnings Per Share | (0.30) X | ||||
| Beta | -116.6 | ||||
| Market Capitalization | 55 | ||||
| Total Asset | 10.56 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Immunotech Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immunotech Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immunotech Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immunotech Laboratories Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunotech Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. For information on how to trade Immunotech Stock refer to our How to Trade Immunotech Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunotech Laboratories. If investors know Immunotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunotech Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.30) |
The market value of Immunotech Laboratories is measured differently than its book value, which is the value of Immunotech that is recorded on the company's balance sheet. Investors also form their own opinion of Immunotech Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Immunotech Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunotech Laboratories' market value can be influenced by many factors that don't directly affect Immunotech Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunotech Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunotech Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunotech Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.